Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Leukemia|November 11, 1999
New system for assessing the prognosis of refractory anemia patientsA Matsuda, I Jinnai, F Yagasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1997
[Plasma cell leukemia associated with monocytosis]K Yoshida, K Aida, T Horibe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 1998
[Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid]K Itoh, W Gotoh, F Yagasaki, et al.
International Journal of Hematology|March 11, 1999
Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study GroupM Yoshida, M Karasawa, T Naruse, et al.
Annals of Hematology|March 21, 2002
Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphomaD Wakao, I Murohashi, K Tominaga, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 10, 2008
L1503R is a member of group I mutation and has dominant-negative effect on secretion of full-length VWF multimers: an analysis of two patients with type 2A von Willebrand diseaseT Kashiwagi, T Matsushita, Y Ito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 13, 1999
[Atypical chronic myeloid leukemia presenting with trilineage dysplasia and IgG (lambda) type monoclonal gammopathy]K Itoh, T Kashimura, Y Kobayashi, et al.
Leukemia|July 1, 1996
Expression of costimulatory molecules in human leukemiasN Hirano, T Takahashi, T Takahashi, et al.
Leukemia Research|August 26, 1998
A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study GroupK Ohnishi, M Tomonaga, N Kamada, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 24, 1998
[Clinical efficacy of fosfomycin in combination with sulbactam/cefoperazone in the treatment of severe infections complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBT/CPZ]K Kitamura, H Hirai, N Hosoya, et al.
Pageof 12